Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-029852

Director bought 84 shares at an average $5.11 ($429)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Young Caroline Director 2025-05-01 Purchase 10b5-1 +4 $4.86 $19 32,489 D
Young Caroline Director 2025-05-02 Purchase 10b5-1 +4 $4.75 $19 32,493 D
Young Caroline Director 2025-05-05 Purchase 10b5-1 +4 $4.68 $19 32,497 D
Young Caroline Director 2025-05-06 Purchase 10b5-1 +4 $4.60 $18 32,501 D
Young Caroline Director 2025-05-07 Purchase 10b5-1 +4 $4.71 $19 32,505 D
Young Caroline Director 2025-05-08 Purchase 10b5-1 +4 $4.50 $18 32,509 D
Young Caroline Director 2025-05-09 Purchase 10b5-1 +4 $4.78 $19 32,513 D
Young Caroline Director 2025-05-12 Purchase 10b5-1 +4 $5.25 $21 32,517 D
Young Caroline Director 2025-05-13 Purchase 10b5-1 +4 $5.67 $23 32,521 D
Young Caroline Director 2025-05-14 Purchase 10b5-1 +4 $5.68 $23 32,525 D
Young Caroline Director 2025-05-15 Purchase 10b5-1 +4 $5.20 $21 32,529 D
Young Caroline Director 2025-05-16 Purchase 10b5-1 +4 $5.37 $21 32,533 D
Young Caroline Director 2025-05-19 Purchase 10b5-1 +4 $4.92 $20 32,537 D
Young Caroline Director 2025-05-20 Purchase 10b5-1 +4 $5.41 $22 32,541 D
Young Caroline Director 2025-05-21 Purchase 10b5-1 +4 $5.05 $20 32,545 D
Young Caroline Director 2025-05-22 Purchase 10b5-1 +4 $5.10 $20 32,549 D
Young Caroline Director 2025-05-23 Purchase 10b5-1 +4 $5.14 $21 32,553 D
Young Caroline Director 2025-05-27 Purchase 10b5-1 +4 $5.27 $21 32,557 D
Young Caroline Director 2025-05-28 Purchase 10b5-1 +4 $5.68 $23 32,561 D
Young Caroline Director 2025-05-29 Purchase 10b5-1 +4 $5.66 $23 32,565 D
Young Caroline Director 2025-05-30 Purchase 10b5-1 +4 $4.93 $20 32,569 D
Open-market purchases · 84 sh · avg $5.11 · $429
Loading xslF345X05/wk-form4_1749213436.xml…